Intrinsic value of Innate Pharma S.A. (IPHA)
Live fair value data for Innate Pharma S.A. (IPHA) is currently unavailable. Please check again shortly.
Current Price: $240.00
Valuation: Undervalued
Confidence: 6.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Innate Pharma S.A. (IPHA) undervalued or overvalued?
Based on the current model output, Innate Pharma S.A. appears to be undervalued with a upside of 23.00%.
Fair value vs market price — Innate Pharma S.A. (IPHA)
Unlock premium access to view the live fair value comparison against current market price for IPHA.
Frequently Asked Questions - IPHA
How is IPHA intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for IPHA.
Is IPHA undervalued or overvalued right now?
IPHA is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for IPHA: open their intrinsic value pages.